Chicken Alfredo meals at Walmart and Kroger recalled after 3 deaths, 16 hospitalizations
FreshRealm issued the recall Tuesday for refrigerated chicken fettuccine Alfredo meals sold nationwide at Kroger and Walmart stores under Marketside and Home Chef brand names, the U.S. Department of Agriculture Food Safety and Inspection Service (FSIS) announced.
The outbreak has been linked to three deaths three deaths, a pregnancy loss and 16 hospitalizations, according to the Centers for Disease Control and Prevention (CDC). The deaths were reported in Illinois, Michigan and Texas.
Illness began between July 24, 2024, and May 10, 2025, with at least 17 people reporting illnesses across 13 states, according to the agencies.
The outbreak is currently under investigation by the CDC, FSIS and Food and Drug Administration.
"The investigation will focus on how Listeria may have entered the product, and whether it entered from a FreshRealm facility, or through any of the ingredients that FreshRealm received from external ingredient suppliers," the company said in a statement.
The recalled products are:
32.8 oz. packages of "MARKETSIDE GRILLED CHICKEN ALFREDO WITH FETTUCCINE Tender Pasta with Creamy Alfredo Sauce, White Meat Chicken and Shaved Parmesan Cheese" with best-by date 06/27/25 or earlier.
12.3 oz. packages of 'MARKETSIDE GRILLED CHICKEN ALFREDO WITH FETTUCCINE Tender Pasta with Creamy Alfredo Sauce, White Meat Chicken, Broccoli and Shaved Parmesan Cheese' with best-by date 06/26/25 or earlier.
12.5 oz. packages of 'HOME CHEF Heat & Eat Chicken Fettuccine Alfredo with pasta, grilled white meat chicken, and Parmesan cheese' with best-by date 06/19/25 or earlier.
The products can also be identified by the establishment numbers 'EST. P-50784,' 'EST. P-47770' or 'EST. P-47718' found on the side of the packaging.
Consumers who may have purchased the products are urged not to consume them and either thrown them away or return them to the location they were purchased. The CDC also recommends cleaning any refrigerators, containers or surfaces the meal may have touched, as listeria can easily spread.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
5 hours ago
- Daily Mail
Experts discover the cause of 'enormous increase' of cancers in young people... and the true toll it takes
Experts have revealed the reason why an increasing number of young adults are now found to be suffering from colon cancer. Early onset colorectal cancer has become the leading cause of cancer-related deaths for men under 50 and the second-leading cause for women under 50 in the US. Over 50,000 Americans are expected to die from colorectal cancer this year, while 150,000 are predicted to be diagnosed with the disease. While still a minority, experts remain concerned about increasing cases among younger people as officials estimate 2,600 new cases among those under 50. Studies also suggest that cases in people between 20 to 24 have risen by 185 percent while the CDC noted a 333 percent increase in cases among teenagers between 15 to 19 as of 2024. Cases are also expected to double between 2010 and 2030, after having risen two percent a year since the early 2000s. But now, researchers from the Dana-Farber Cancer Institute and Harvard Medical School found that patients with early-onset colorectal cancers often experience delays in diagnosis because neither physicians nor patients initially suspect that they are suffering from the disease. As a result, doctors are more likely to diagnose patients when they are at advanced stages of the disease - leading to aggressive forms of treatment and lower chances of survival. According to research, reasons such as non-obvious symptoms, lack of routine screening and confusion with other conditions such as irritable bowel syndrome and Crohn's disease can contribute to a delay in diagnosis. And not only do young people experience a delay in diagnosis but they also endure hardships unique to their age group such as infertility, medical debt and mental health struggles. Lead author Sara K. Char, a clinical fellow in Hematology and Oncology at Dana-Farber Cancer Institute, said: 'The incidence of GI cancers in adults younger than age 50 is rising globally. 'Ongoing research efforts investigating the biology of early-onset GI cancers are critical to developing more effective screening, prevention, and treatment strategies.' The researchers conducted a comprehensive literature review of multiple studies focusing on early-onset colorectal, esophagogastric and pancreatic cancers from across the world. Additionally, they also reviewed previous studies on rare early onset gastrointestinal GI cancers including appendix and neuroendocrine tumors. The scientists particularly focused on studies that highlighted the risk factors, common patterns, observable traits and underlying genetic reasons that cause colon cancer. Results showed that one of the most common reasons why young people were not being treated during early stages of colon cancer was due to late diagnosis. Most colorectal cancers start as colon polyps - tumors in the wall of the colon - that are usually non-cancerous and can be removed during colonoscopies. However, sometimes these tumors can turn cancerous if left untreated for prolonged periods of time, according to John Hopkins University. Additionally, colorectal cancers do not show symptoms in the early stages - making regular screening tests such as a coloscopy essential to ensure good colon health. However, the CDC recommends that people should begin to get colonoscopies at the age of 45 and repeat every five years. The agency notes that people under the age of 45 suffering from Crohn's disease, ulcerative colitis or have a family history of colon cancer should also get tested. But the CDC has no such recommendations for young people experiencing symptoms that may not have a family history of colon cancer or are suffering from related diseases - leading to delayed diagnosis. And common symptoms such as abdominal pain, changes in bowel habits (diarrhea, constipation), rectal bleeding and weight loss can also be misdiagnosed as IBS or Crohn's disease. A lack of clear early symptoms combined with irregular screening can lead to delays in colon cancer diagnosis. Along with this, the researchers involved in this study also revealed the toll a cancer diagnosis can take on a young adult - which can further fuel delays in diagnosis or treatment. The scientists noted that despite being in their peak earning years, young patients are more likely to experience financial hardship because of their cancer diagnosis due to treatment costs. In a 2024 survey, the American Cancer Society Cancer Action Network found that nearly half of cancer patients and survivors had medical debt of over $5,000 despite most of them being insured. They also found that those with cancer-related medical debt are three times more likely to be behind on recommended cancer screenings. Furthermore, 27 percent of those surveyed with cancer-related medical debt have gone without adequate food and 25 percent have skipped or delayed care. Nearly 50 percent of people saw their credit scores decrease and 30 percent had difficulty qualifying for loans - making their financial condition even worse. Though official guidelines for early-onset and average-onset cancers are the same, researchers emphasized that younger patients are more likely to receive aggressive colon cancer treatment, often without a survival advantage. These aggressive forms of treatment can also damage a patient's chances of having a children as excessive radiation can damage and kill reproductive cells and tissues in the body. Though the American Society of Clinical Oncology recommends that oncologists discuss treatment-related fertility concerns with patients of reproductive age, a recent study found that 50 percent of patients reported that their doctors did not talk to them about the impact of their disease or treatment on having future children. This can make it difficult for couples' or individuals to conceive over time and impact their quality of life. The study also found that early-onset colorectal cancer survivors are also more likely to report problems with anxiety, body image and sexual dysfunction compared to advanced onset survivors. They are also more likely to report worse social functioning and physical quality of life. Additionally, male patients with early onset colorectal cancers are more likely to suffer depression than those diagnosed with average onset colorectal cancers. As a result, the involved researchers concluded that 'a better understanding of underlying etiologies, optimized screening strategies and improved survivorship support is necessary' for young adults. The study was published today in BJS journal by Oxford University Press.
The Independent
5 hours ago
- The Independent
Colon cancer is spiking in young adults. Scientists are blaming the American diet
Rates of colorectal and other gastrointestinal cancers are rising in Americans under the age of 50, researchers said Tuesday. They may know why. An increased risk of early-onset gastrointestinal cancers is associated with obesity, which is also rising in the U.S. That's what scientists say is a 'leading theory' for the surge - noting a 2019 study that found women who were considered obese had nearly double the risk of developing early-onset colorectal cancer. Close to half of all U.S. adults are predicted to be obese by 2030, according to research released the same year. The chronic condition can cause inflammation and higher levels of insulin that increases peoples' risk of getting cancer, including several types of gastrointestinal cancers, according to the Centers for Disease Control and Prevention. Other risk factors include smoking, drinking alcohol, eating a Western-style diet and non-alcoholic fatty liver disease. Earlier this year, new research pointed to the impact of a toxin in the gut, known as colibactin, that can inflict DNA damage on colon cells that leads to the development of cancer. Colibactin is produced by the bacteria E. coli, which is often responsible for foodborne illness. As of now, the specific cause remains unclear but the U.S. is not alone, researchers said. 'The incidence of GI cancers in adults younger than age 50 is rising globally,' explained Boston's Dana-Farber Cancer Institute oncology fellow Dr. Sara Char. Gastrointestinal cancer rates in the US In the U.S., scientists found that early-onset cases have shown a 'marked increase' in both American men and women since the mid-1990s. In comparison to American adults born in 1950, those born in 1990 have twice the risk of developing colon cancer and four times the risk of developing rectal cancer, the researchers found. Furthermore, early-onset colorectal cancer has become the leading cause of cancer-related deaths in U.S. for men under 50. For women in the same age group, it's the second-leading cause of cancer-related deaths. Colorectal cancer, the most common type of gastrointestinal cancer, also affects Black, Hispanic, Indigenous, and Asian people disproportionately. Changing treatment These and other related findings signal a worrying shift — and potentially a need for updated treatment practices, the researchers noted. Patients with early-onset colorectal cancers often experience delays in diagnosis because neither doctors, nor their patients, suspect cancer and doctors are more likely to diagnose patients when they are at advanced stages of the disease. Younger patients are more likely to receive aggressive treatment, 'often without a survival advantage,' they said. Colorectal cancer is the third-leading cause of cancer-related deaths in American men and the fourth-leading cause in women. Overall, it's the second most common cause of U.S. cancer deaths, and the American Cancer Society says it's expected to cause about 52,900 deaths this year. The researchers pointed out that younger patients are more likely to experience financial hardship because of their diagnosis and problems with body image and mental health, as well as a worse quality of life. 'Ongoing research efforts investigating the biology of early-onset GI cancers are critical to developing more effective screening, prevention, and treatment strategies,' Char, the paper's lead author, said.
Medical News Today
8 hours ago
- Medical News Today
Vaccine additive thimerosal deemed unsafe by the CDC: 3 things to know
The United States federal government may soon ban vaccines that use an ingredient called is a preservative that — due to questions about its safety throughout the decades — has mostly been avoided by vaccine it still features in some flu shots, which has prompted questions about how a potentially impending ban on thimerosal may affect vaccine availability and June 24, 2025, an advisory committee for the Centers for Disease Control and Prevention (CDC) voted against the use of an additive called thimerosal in their presentation, the advisory panel called thimerosal 'a known neurotoxin' and advised that banning vaccines using this ingredient would be 'a good place to start with Making America Healthy Again.'Thimerosal is an additive used as a preservative — that is, a substance that helps keep the active ingredients in vaccines fresh and why is it controversial, and what do we really know about its safety?Medical News Today examined what is known about thimerosal's current use and safety profile and answered these and other questions with the assistance of Monica Gandhi, MD, MPH, an infectious disease specialist and professor of medicine at the University of California, San is thimerosal a controversial vaccine ingredient?'Thimerosal is a mercury-based preservative that can help vaccines last longer,' Gandhi is precisely what renders it controversial, since, as the World Health Organization (WHO) notes, mercury is a liquid metal that poses various risks to human can affect a number of bodily systems, including the nervous system, digestive system, immune system, the lungs, kidneys, skin, and 'high levels of mercury can be toxic to a developing fetus, for eample,' Gandhi pointed this reason, she added, 'thimerosal has been taken out of most childhood vaccines but can still be found in some including the multidose influenza vaccine.'However, thimerosal contains a very specific, modified form of mercury called ethylmercury, which, according to the WHO, 'does not pose a health risk,' as it quickly breaks down after entering the body, and is subsequently thimerosal cause autism or neurodevelopmental conditions?Another part of the thimerosal controversy is the fact that it was mistakenly linked to autism by a now-discredited and retracted study.'Multiple studies have shown no safety concerns with thimerosal in terms of causing autism or neurodevelopmental issues,' said Gandhi. The advisory panel calling for thimerosal's ban appeared to further fuel the controversy by citing a publication whose alleged author has since explained in media interviews does not exist, leading to its removal from the presentation.'[T]his reference —showing an association between thimerosal and neurodevelopmental delays in animals — did not exist and was subsequently removed from the presentation when the error was pointed out,' Gandhi to Reuters, Katherine L. O'Brien, MD, MPH, director of the Department of Immunization, Vaccines, and Biologicals at the WHO, emphasized that, based on current medical evidence, the organization finds thimerosal thimerosal considered safe?'Thimerosal has been reviewed multiple times by multiple agencies, including WHO, and it's clear from the evidence that there is no evidence of harm from the use of thimerosal.'— Katherine L. O'Brien, MD, MPHHow might banning thimerosal affect vaccine availability?While it is largely considered safe, in the U.S., thimerosal is already rarely used in vaccines. In 1999, the American Academy of Pediatrics and the U.S. Public Health Service issued a call to remove thimerosal from most childhood ingredient has thus been avoided, as a precautionary measure, since 2001, according to the only exception to this, as Gandhi pointed out, is the multidose flu shot. 'Before we knew thimerosal was safe in multiple animal and human studies, it was removed from almost all childhood vaccines. However, thimerosal is still in influenza vaccine, especially the ones that come in multidose vials, since the agent serves as powerful preservative protecting the vaccine from bacterial or fungal contamination.'— Monica Gandhi, MD, MPHThe greatest concern with banning thimerosal entirely is that this action could severely affect vaccine availability in the community.'Banning thimerosal is simply not indicated by the scientific evidence,' Gandhi insisted.'Moreover, this could result in less stock of influenza vaccine being produced or a move away from the multidose vials, which could limit vaccine availability of the flu vaccine this coming respiratory season,' she told to national immunization data provided by the CDC, flu vaccinations among children in the U.S. are already on the decline, even as flu cases were surging significantly during the last flu these shots become less available during the next flu season, this viral infection, which is typically easily kept at bay, could cause more severe issues among the to the CDC, the flu can cause serious complications in young children, including pneumonia and inflammation of the brain (encephalitis).
